SCHEMBL6216737

SCHEMBL6216737

CCOC(=O)c1sc2nc(SC)nc(-c3ccsc3)c2c1N

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LHCGR P22888 5/20 0.52
▸ KDM4E B2RXH2 7/20 0.50
▸ MAPT P10636 7/20 0.50
▸ HPGD P15428 5/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ GAA P10253 4/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ ATM Q13315 2/20 0.50
▸ GLA P06280 2/20 0.50
▸ CASP1 P29466 1/20 0.50
▸ CASP7 P55210 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ CDC7 O00311 1/20 0.49
▸ DBF4 Q9UBU7 1/20 0.49
▸ TSHR P16473 2/20 0.47
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ RCE1 Q9Y256 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217590 0.88 LHCGR (0.53) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6218708 0.87 KDM4E (0.45) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6216192 0.87 ALDH1A1 (0.62) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6217584 0.86 ALDH1A1 (0.51) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6214494 0.85 LHCGR (0.59) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6216798 0.85 LHCGR (0.52) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL4431522 0.83 LHCGR (0.62) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6218864 0.83 KDM4E (0.58) KDM4EMAPTHPGDALDH1A1GAA
SCHEMBL6216323 0.83 LHCGR (0.51) LHCGRKDM4EMAPTHPGDALDH1A1
SCHEMBL6219435 0.83 CDC7 (0.49) KDM4EMAPTHPGDALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 — — EP disclosed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 — — US disclosed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 — — US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists LHCGR, GNRHR, FSHR LHCGR 1/4885KDM4E 2123/4885MAPT 4619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback